Prism Pharmaceuticals - Ownership and Business Overview

Medical ProductsCompany

Prism Pharmaceuticals Ownership

Who owns Prism Pharmaceuticals?

Prism Pharmaceuticals is owned by Baxter International. It was acquired on April 18, 2011.

Was Prism Pharmaceuticals formerly PE-backed?

Yes. Prism Pharmaceuticals was formerly owned by 2 private investors.

Prism Pharmaceuticals Business Overview

Where is Prism Pharmaceuticals headquartered?

Prism Pharmaceuticals is headquartered in King of Prussia, Pennsylvania.

What sector is Prism Pharmaceuticals in?

Prism Pharmaceuticals is a medical products company.

When was Prism Pharmaceuticals founded?

Prism Pharmaceuticals was founded in 2003.

Medical Products M&A Summary in 2011

Out of 60 sectors in the Mergr database, medical products ranked 7 in number of deals in 2011. The largest medical products acquisition in 2011 was Synthes - which was acquired by Johnson & Johnson for $19.3B.

Join Mergr to view all 187 acquisitions of medical products companies in 2011, including 39 acquisitions by private equity firms, and 148 by strategics.

Prism Pharmaceuticals, Inc.

1016 West Ninth Avenue Suite 130,
King of Prussia, Pennsylvania 19406
United States,
(610)265-7710
www.prismpharma.com

​Prism, located in King of Prussia, Pennsylvania, is a leading specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products. Prism is focused on recognizing unfulfilled opportunities in existing compounds that target acute care cardiovascular needs and comprehensively developing them to achieve their full market potential.


 Subscribe to unlock this and 201,598
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.